Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PTC PLASTIC PANCREATIC AND BILIARY STENTING PROCEDURES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PTC METAL PANCREATIC AND BILIARY STENTING PROCEDURES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. JAUNDICE

5.2.1. Market size and forecast

5.3. STONE REMOVAL

5.3.1. Market size and forecast

5.4. POSTOPERATIVE OR POSTTRAUMATIC BILE LEAKAGE

5.4.1. Market size and forecast

5.5. OTHERS

5.5.1. Market size and forecast

Chapter: 6 PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Percutaneous Transhepatic Cholangiography Market by Type
6.2.5. North America Percutaneous Transhepatic Cholangiography Market by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Percutaneous Transhepatic Cholangiography Market by Type
6.3.5. Europe Percutaneous Transhepatic Cholangiography Market by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Percutaneous Transhepatic Cholangiography Market by Type
6.4.5. Asia-Pacific Percutaneous Transhepatic Cholangiography Market by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast

6.5.4. LAMEA Percutaneous Transhepatic Cholangiography Market by  Type
6.5.5. LAMEA Percutaneous Transhepatic Cholangiography Market by Application 

Chapter: 7 COMPANY PROFILES

7.1. B. BRAUN MELSUNGEN AG

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. KARL STORZ

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. CARDINAL HEALTH

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. GE HEALTHCARE

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments